Vietnam Investment Review on MSN9d
Lion TCR's Liocyx-M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV-Related Hepatocellular Carcinoma
Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from ...
Glasgow Times on MSN1d
Drug combination nearly erases liver cancer in major breakthrough
A groundbreaking cancer study led by Professor Tom Bird from the Cancer Research UK Scotland Institute has discovered a drug ...
ascopubs.org25d
Germline pathogenic variants in a cohort of individuals with biliary tract cancer.
Risk of proteinuria with atezolizumab plus bevacizumab versus lenvatinib in first-line systemic treatment for hepatocellular carcinoma. End-of-life (EOL) outcomes and healthcare utilization for ...
news.stv1d
‘I am living with advanced liver cancer - exciting trial has seen tumour shrink by half’
A man living with advanced liver cancer has seen his tumour shrink by over half as “exciting” new clinical trials are ...
ascopubs.org25d
Adjuvant chemotherapy or chemo-radiation in gallbladder cancer: A phase III randomized controlled study (ACCELERATE trial).
Adjuvant cytokine-induced killer cell immunotherapy in hepatocellular carcinoma: Extended follow-up of a randomized controlled trial and post-treatment immune cell profiling. Nivolumab (NIVO) plus ...